Monopar Therapeutics
MNPR
#7537
Rank
A$0.70 B
Marketcap
A$104.25
Share price
-1.84%
Change (1 day)
-26.47%
Change (1 year)

EPS for Monopar Therapeutics (MNPR)

EPS in 2026 (TTM): A-$2.82

According to Monopar Therapeutics's latest financial reports the company's current EPS (TTM) is A-$2.89. In 2025 the company made an earnings per share (EPS) of A-$2.79 an increase over its 2024 EPS that were of A-$6.21.

EPS history for Monopar Therapeutics from 2016 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$2.820.89%
2025A-$2.79-54.99%
2024A-$6.2135.2%
2023A-$4.59-26.75%
2022A-$6.2713.7%
2021A-$5.5125.86%
2020A-$4.3828.89%
2019A-$3.4045.28%
2018A-$2.34-80.5%
2017A-$12.001296.33%
2016A-$0.86

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
A-$2.04-29.32%๐Ÿ‡บ๐Ÿ‡ธ USA